QualityStocksNewsBreaks Archives - Page 822 of 1423

TuesdayDec 01, 2020 1:19 pm

QualityStocksNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Releases Test Results for Control of Threat to $25 Billion Banana Industry

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) has announced initial test results of its mustard-derived organic biopesticide formulation designed to control Fusarium wilt TR4, a destructive pathogen threatening the global banana industry, which is valued at $25 billion. Completed via third-party independent laboratory CyberAgrot SAS in Colombia, the testing reported 100% control Fusarium wilt TR4, known as Panama disease. The disease led to the declaration of a national state of emergency in Colombia in 2019. Based on what the company has been able to determine, complete control of this disease has never been achieved. The company is now planning more advanced…

TuesdayDec 01, 2020 1:01 pm

QualityStocksNewsBreaks – Sanwire Corp. (SNWR) Retires $750K of Debt in Continued Enhancement of Balance Sheet

Sanwire (OTC: SNWR), focused on technologies for the entertainment industry, today announced that it has reached agreements with multiple stakeholders to reduce the company's outstanding debt by approximately $750,000 in principal and interest. The stakeholders, representing founding members, management team and early investors of Intercept Music Inc., a 100% wholly-owned subsidiary of Sanwire, have agreed to exchange their debt for equity in the company. According to the update, the transaction will be booked in the company's fourth quarter 2020 financial statement and posted in its year-end disclosure statement filing. “We continue to explore ways to enhance our balance sheet to…

TuesdayDec 01, 2020 12:33 pm

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) Moves Toward Anti-Dilution Policy, Commercial Launch of Cryptocurrency Segment

ISW Holdings (OTC: ISWH), a global brand management holdings company, today announced that it is negotiating with noteholders toward establishing a new agreement that will form the foundation for its emerging anti-dilution policy designed to protect the value of its common stock and return more of that value to its shareholders. According to the update, the current negotiation contemplates an agreement whereby noteholders will exchange their notes for preferred restricted shares, reducing debt on the balance sheet and protecting shareholders against dilution. “We are moving toward the commercial launch of our Cryptocurrency segment, which was established this summer through our…

TuesdayDec 01, 2020 12:26 pm

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Notes Key Developments for Recent PowerTap Investment

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, has released an update on PowerTap Hydrogen Fueling Corp. Clean Power invested in PowerTap earlier this year. PowerTap is currently working to complete its newest design of a patented onsite hydrogen production and dispensing technology designed for use in the North American hydrogen-vehicle market. This third-generation version includes significant advantages over earlier PowerTap units as well as other hydrogen-fueling technologies available in the space. For instance, the station can go live in mere weeks and can be fully assembled and tested prior to delivery, bypassing the need for…

TuesdayDec 01, 2020 11:56 am

QualityStocksNewsBreaks – Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF) Announces Q3 2020 Results

Exro Technologies (TSX.V: EXRO) (OTCQB: EXROF), a leading technology company that has developed a new class of power electronics for electric motors and powertrains, on Monday released its third quarter 2020 financial results for the nine months ended Sept. 30, 2020. “The third quarter was an eventful period as we achieved several key milestones. First and foremost, we successfully closed in July the short form prospectus offering of C$8,000,000 at a price of $0.70 per unit, pursuant to which the company issued 11,428,571 units,” said Exro CFO John Meekison. “The net proceeds from this offering will enable us to do…

TuesdayDec 01, 2020 11:33 am

QualityStocksNewsBreaks – Wrap Technologies Inc.’s (NASDAQ: WRAP) Flagship Product — BolaWrap — Captured On Bodycam Video

Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, announced that BolaWrap(R), its patented, hand-held remote restraint device, was used by the Virginia Police Department in Minnesota earlier this month. The successful deployment of the revolutionary device was captured on bodycam video footage, which WRAP will release today. The footage will be shown during a live Zoom webinar, slated to begin at 10 a.m. ET; the company will also upload the video to its YouTube channel following the webinar. In addition to the footage, the webinar will feature an overview of the BolaWrap as well as a recorded interview with Virginia…

TuesdayDec 01, 2020 10:59 am

QualityStocksNewsBreaks – Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) (OMX: JOSE) Issues Share Capital, Voting Rights Update

Josemaria Resources (TSX: JOSE) (OTCQB: JOSMF) (OMX: JOSE), a Canadian-based natural resources company, on Monday released an update regarding share capital and voting rights. According to the update, the number of issued and outstanding shares of the company has increased to 301,429,109 common shares with voting rights as of Nov. 30, 2020, in accordance with the Swedish Financial Instruments Trading Act and as a result of the issuance of common shares pursuant to the terms of previously announced credit facilities. To view the full press release, visit https://ibn.fm/2nG6Z About Josemaria Resources Inc. Josemaria Resources is a Canadian natural resources company…

TuesdayDec 01, 2020 10:29 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Commences Site Recruitment for Upcoming Acclaim-1 Clinical Trial

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, on Monday announced its commencement of clinical trial site recruitment for its upcoming Acclaim-1 clinical trial for the treatment of non-small cell lung cancer (“NSCLC”). The company’s timing of patient recruitment and enrollment keeps it on track for its Acclaim-1 clinical trial to commence in the first-half of 2021. “Our clinical team is engaging with prestigious cancer centers and research institutions across the U.S. to ensure we select optimal study sites, which play an important role in the success of a clinical trial,” said Rodney Varner,…

TuesdayDec 01, 2020 9:00 am

QualityStocksNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Appointment of New VP of Translational Medicine

VistaGen Therapeutics (NASDAQ: VTGN) has appointed a new vice president of translational medicine. A pioneer in the development of neuroactive steroids known as pherines, Louis Monti, MD., PhD., developed the original scientific platform that enabled the early research and development of VistaGen's PH94B and PH10. The two intranasal neuroactive steroid drug candidates (pherines) have potential for the rapid-onset treatment of anxiety and depression disorders, respectively. VistaGen is a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders. Throughout…

MondayNov 30, 2020 3:23 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Enters Strategic Agreement for Expansion into EU Market

Brain Scientific’s (OTCQB: BRSF) Vice President of Marketing, Stuart Bernstein, has written an article for Health Care Business News titled, “COVID's influence on neurology drives need for disposable technologies.” The piece discusses increased concern for health care and frontline workers treating emergent cases for COVID-19 patients developing neurological symptoms and conditions, as well as a critical need for testing solutions. The article reads, “Sudden onset of seizures, metabolic encephalopathy, stroke and other neurological conditions can negatively impact COVID patient outcomes and morbidity rates. Growing evidence of the commonality of neurological symptoms in COVID patients, coupled with challenges in accessibility, efficiency…

Site Search

Company Search

Category: QualityStocksNewsBreaks